Harnessing the CD8+ T-cell subsets with stemness for tumor immunotherapy

Wei Wang; Yukai He; Sha Wu

doi:10.2217/fon-2018-0238

Harnessing the CD8+ T-cell subsets with stemness for tumor immunotherapy

Wei Wang
, Yukai He
, Sha Wu

Gastroenterology

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	2433-2436
Number of pages	4
Journal	Future Oncology
Volume	14
Issue number	24
DOIs	https://doi.org/10.2217/fon-2018-0238
State	Published - Oct 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

CD8+ T cells
Stemness
Tumor immunotherapy

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.2217/fon-2018-0238

Cite this

@article{8ab9a51e8b494ebcb5488a687c534202,

title = "Harnessing the CD8+ T-cell subsets with stemness for tumor immunotherapy",

keywords = "CD8+ T cells, Stemness, Tumor immunotherapy",

author = "Wei Wang and Yukai He and Sha Wu",

note = "Funding Information: This work was supported by the National Natural Science Foundation of China (number: 81372781) and Provincial Natural Science Foundation of Guangdong (number: 2017A030313872). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript",

year = "2018",

month = oct,

doi = "10.2217/fon-2018-0238",

language = "English (US)",

volume = "14",

pages = "2433--2436",

journal = "Future Oncology",

issn = "1479-6694",

publisher = "Taylor and Francis Ltd.",

number = "24",

}

TY - JOUR

T1 - Harnessing the CD8+ T-cell subsets with stemness for tumor immunotherapy

AU - Wang, Wei

AU - He, Yukai

AU - Wu, Sha

N1 - Funding Information: This work was supported by the National Natural Science Foundation of China (number: 81372781) and Provincial Natural Science Foundation of Guangdong (number: 2017A030313872). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript

PY - 2018/10

Y1 - 2018/10

KW - CD8+ T cells

KW - Stemness

KW - Tumor immunotherapy

UR - https://www.scopus.com/pages/publications/85054461381

UR - https://www.scopus.com/pages/publications/85054461381#tab=citedBy

U2 - 10.2217/fon-2018-0238

DO - 10.2217/fon-2018-0238

M3 - Review article

C2 - 30141349

AN - SCOPUS:85054461381

SN - 1479-6694

VL - 14

SP - 2433

EP - 2436

JO - Future Oncology

JF - Future Oncology

IS - 24

ER -

Harnessing the CD8+ T-cell subsets with stemness for tumor immunotherapy

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this